GOMEZ MONTERREY, ISABEL MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.885
EU - Europa 3.298
NA - Nord America 3.171
SA - Sud America 630
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 11.093
Nazione #
US - Stati Uniti d'America 3.019
SG - Singapore 2.197
RU - Federazione Russa 1.523
CN - Cina 798
IT - Italia 542
BR - Brasile 538
HK - Hong Kong 373
VN - Vietnam 272
UA - Ucraina 240
DE - Germania 204
FI - Finlandia 161
NL - Olanda 136
IE - Irlanda 132
SE - Svezia 104
CA - Canada 92
GB - Regno Unito 87
IN - India 57
AR - Argentina 37
MX - Messico 37
FR - Francia 36
ZA - Sudafrica 33
AT - Austria 32
CI - Costa d'Avorio 31
TR - Turchia 25
ES - Italia 23
ID - Indonesia 22
PL - Polonia 22
BD - Bangladesh 20
JP - Giappone 20
KR - Corea 19
CO - Colombia 15
EC - Ecuador 13
AE - Emirati Arabi Uniti 8
BE - Belgio 8
MA - Marocco 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CL - Cile 7
IL - Israele 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
KE - Kenya 6
VE - Venezuela 6
IR - Iran 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
PT - Portogallo 5
DZ - Algeria 4
GE - Georgia 4
GR - Grecia 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
EG - Egitto 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
UG - Uganda 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GM - Gambi 1
HR - Croazia 1
MK - Macedonia 1
NA - Namibia 1
NE - Niger 1
Totale 11.078
Città #
Singapore 946
Chandler 439
Moscow 404
Hong Kong 372
Beijing 290
Jacksonville 233
Ashburn 185
Princeton 134
Santa Clara 132
Millbury 112
Amsterdam 108
Nanjing 107
Napoli 107
Los Angeles 101
Naples 89
Ho Chi Minh City 83
Hefei 81
Buffalo 73
Boston 60
Dallas 60
São Paulo 59
Des Moines 57
Ottawa 53
Wilmington 48
Redondo Beach 43
Munich 41
New York 40
The Dalles 37
Hanoi 36
Seattle 30
Dong Ket 28
Turku 23
Chicago 21
Fisciano 21
London 21
Nanchang 21
Salerno 21
Shenyang 21
Mexico City 20
Montreal 20
Warsaw 20
Hebei 19
Kronberg 19
Rio de Janeiro 19
Stockholm 19
Orem 18
Biên Hòa 17
Brooklyn 17
Jiaxing 17
Seoul 17
Tianjin 17
Changsha 15
Haiphong 15
Johannesburg 15
Woodbridge 15
Denver 14
Falkenstein 14
Lawrence 14
Atlanta 13
Frankfurt am Main 13
Brasília 12
Chennai 12
Poplar 12
Da Nang 11
Milan 11
Norwalk 11
Vienna 11
Curitiba 10
Helsinki 10
Houston 10
Parma 10
Boardman 9
Hải Dương 9
Nuremberg 9
Tokyo 9
Toronto 9
Ankara 8
Charlotte 8
Dublin 8
Goiânia 8
Kochi 8
Nakano 8
Phoenix 8
San Francisco 8
Bắc Giang 7
Campinas 7
Manaus 7
North Bergen 7
Recife 7
Rome 7
Tashkent 7
Ann Arbor 6
Bắc Ninh 6
Hangzhou 6
Orange 6
Paris 6
Querétaro 6
Baronissi 5
Belo Horizonte 5
Brussels 5
Totale 5.433
Nome #
Short-length derivatives of cell-penetrating peptides for ocular drug delivery 200
New Antiviral INSTIs: Design, Synthesis And Biological Evaluation. 142
Characterization of New TRPM8 Modulators in Pain Perception 136
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 135
Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy 133
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity 132
1,3-Dioxoperhydropyrido[2,1-c]pyrimidine derivatives as Cholecyctokinin antagonista 131
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization 130
Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators 125
Pursuing the Development of New Antiviral INSTIs 117
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 116
D-Amino Acids Containing Temporin L Analogues 113
N-substitued tryptamines as TRPM8 channel modulators 113
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 112
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 110
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 108
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities 108
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 108
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 108
Pursuing the Development of New Antiviral Entry Inhibitors 107
Urantide Conformation and Interaction with the Urotensin-II Receptor 106
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 106
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 104
Continuous-flow synthesis of thiazolidine libraries: one-pot two steps protocol optimization 103
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 102
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 102
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 101
DTNQ-based anticancer derivatives as selective glucose penetration inhibitors 101
Synthesis of a New Series of [Indoline3, 2’-thiazolidine] - Based p53 modulators 101
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 100
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 99
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 98
Development of Cyclic Peptide Inhibitors of GRK2 97
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 96
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 96
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 95
Antioxidant profile and in vitro antiproliferative and cardioprotective properties of typical red and white wines from vineyards cultivated in Scafati (Salerno, Italy) 95
Dihydrithieno[2,3-b]naphto-4,9-dione analogues as anticancer agents: Synthesis and in cell pharmacological studies. 95
A novel route to synthesize Freidinger lactams by microwave irradiation 93
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 93
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 92
Morphicetin analogues containing a new β-turn thiazolidine mimetic 91
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis 91
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 89
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 88
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 88
N-substituted tryptamines as TRPM8 channel modulators 86
Sar Study Of P5u And Urantide Analogues Modified At Position 9 86
Synthesis of 2-Alkyl(aryl)amino-(3,4,6-tri-O-acetyl-1,2-dideoxy-a-D-glucopirano)[2,1-d]-2-oxazolines and ethyl 2-[3-alkyl(aryl)ureido]-2-deoxy-b-D-glucopiranosides from acetylated 2-[3-alkyl(aryl)ureido]-2-deoxy-D-glucopyranoses 85
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 85
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 85
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 82
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structure-activity relationship studies on the substituents at N2-position 81
A facile synthesis of 8-Amino-3-oxoindolizidine derivatives as conformationally restricted ornithyl pseudodipeptides. 81
An efficient synthesis of 8-Amino-3-oxoindolizidine-2-carboxylic acid and derivarives as model peptidomimetics 81
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models 81
Tioureas derivadas de carbohidratos V. Isotiocianato y tioureas dela 2-Amino-2-desoxi-D-glicero-α-L-glucoheptopiranosa 80
D-Amino Acids Containing Temporin L Analogues 78
Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach 78
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase 77
P5U and urantide modifi ed at position 7 with Tpi 76
Le concept d’inhibiteaurs mixtes des metallopeptidase a Zinc: application au developement de noveaux analgesiques et antihypertensives 74
An efficient approach for monosulfide bridge formation in solid-phase peptide synthesis 74
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from fragment Virtual Screening 74
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 72
An Efficient Approach to Aromatic Aminomethylation Using Dichloromethane as Methylene Source 72
Phenacylthiourea and N-thiazolyl derivatives of D-glucasamine 71
Synthesis of cyclic ketomethylene dipeptides 71
Sintesis de hidrobromuros de Glucopirano-[2,1-d]-2-tiazolidinas 70
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structural modifications at the Tryptophan domain 70
Ketomethylenebestatine. Synthesis and aminopeptidase inhibition 70
Cell penetrating peptides in ocular drug delivery: State of the art 70
Synthesis of quinolindione derivatives assisted by microwave irradiation 69
Antioxidant and oxidative effects of grape juices 69
Conformational stability of a(25-35) in the presence of thiazolidine and imidazo[1,5-c]thiazole-5,7-dione derivatives 67
Pharmacological evaluation of IQM-95,333, a highly selective CCK-A receptor antagonist with anxyolitic-like activity in animal models. 65
Synthesis of Ketomethylene-bestatine 65
Novel peptidomimetic as MMP2 inhibitors 65
Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors 65
Synthesis and biological activities of ketomethylene-substituted analogs of neurotensin(8-13) 64
A new series of 1,3-dihydro-imidazo[1,5-c]thiazole-5,7-dione derivatives: synthesis and interaction with Aβ (25-35) amyloid peptide 64
Morphiceptin Analogues Containing a Dipeptide Mimetic Structure: An Investigation on the Bioactive Topology at μ-Receptor 64
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. 64
Synthesis and antimicrobial evaluation of Temporin L analogues containing D-amino acids 63
Characterization of a selective CaMKII peptide inhibitor 63
Antioxidant profile and in vitro cardiac radical-scavenging vs pro-oxidant effects of commercial red grape juices (Vitis vinifera L. cv. Aglianico N.). 62
Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer 62
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors? 61
Prolonged antinociceptive activity of pseudodipeptide analogues of Lys- Trp(Nps) and Trp(Nps)-Lys 61
Synthesis of Glicofurano[2,1-d]imidazolidin-2-ones 60
Stereospecific synthesis of (2R,3S)-3-Amino-2-piperidineacetic acid derivatives for use as conformational constraint in peptides 60
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 60
Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity 60
Ketomethylene analogues of phosphoryl dipeptides related to Phosphoramidon. Synthesis and inhibition of proteases 59
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 59
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents 58
Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: Potent and selective Cholecystokinin-A receptor antagonists. 57
Design, Synthesis and Conformational Studies of New Analogues of Temporins A and L. 57
Efficient Synthesis in Solid-Phase of Freidinger-like lactams by Microwave irradiation 56
Rapid and Efficient Methodology to Perform Macrocyclization Reactions in Solid-Phase Peptide Chemistry 56
Totale 8.751
Categoria #
all - tutte 39.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 70 48 41 68 7 55 33
2021/2022672 11 5 2 14 6 30 11 16 133 48 125 271
2022/2023984 160 65 25 113 111 105 8 88 140 109 40 20
2023/2024547 21 80 68 24 32 32 9 66 13 15 134 53
2024/20253.459 189 188 46 25 58 159 397 201 371 357 1.194 274
2025/20263.881 717 502 692 674 1.105 191 0 0 0 0 0 0
Totale 11.373